Literature DB >> 4031853

Neurological mutation characterized by dysmyelination in NCTR-Balb/C mouse with lysosomal lipid storage disease.

H Weintraub, A Abramovici, U Sandbank, P G Pentchev, R O Brady, M Sekine, A Suzuki, B Sela.   

Abstract

Morphological and biochemical studies were performed on the CNS of neurologically affected NCTR-Balb/C mouse. Histological and electron microscopic techniques demonstrated severe myelin deficiency in the affected brains. Neither the presence of lipid-containing macrophages nor reactive gliosis was apparent. Analysis of myelin-associated lipids and proteins revealed prominent depletion of galactocerebroside, sulfatide, and proteolipid proteins. In contrast to the scarcity of myelin-specific constituents a marked accumulation of GM2 and GM3 gangliosides and several neutral glycolipids, i.e., glucocerebroside, lactosylceramide, gangliotriaosylceramide, and gangliotetraosylceramide were found in affected CNS. These abnormalities were already apparent in 12-day-old pups as well as in 65-day-old mice. A significant deficit in the proportion of long-chain fatty acids (C24), notable in both normal and alpha-hydroxy acids of cerebrosides from affected white matter, was measured. The lack of reactive gliosis, the observed depletion of galactocerebroside and sulfatide at the early age of 12 days, and the relative decrease in long-chain fatty acids in affected CNS strongly suggest a defect in myelinogenesis in this mutant rather than a secondary process of myelin breakdown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031853     DOI: 10.1111/j.1471-4159.1985.tb04044.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Lysosome lipid storage disorder in NCTR-BALB/c mice: spleen and lung lysosomes store unesterified cholesterol but differ in their phospholipid composition.

Authors:  C Bhuvaneswaran; M D Morris
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

2.  Lectin histochemistry of brains from a murine mutant carrying a storage disorder.

Authors:  H Weintroub; E Skutelsky; U Sandbank; A Abramovici; P G Pentchev; J Alroy
Journal:  Histochemistry       Date:  1989

Review 3.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

Review 4.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

5.  Dysmyelination in NCTR-Balb/C mouse mutant with a lysosomal storage disorder. Morphological survey.

Authors:  H Weintraub; A Abramovici; U Sandbank; A D Booth; P G Pentchev; B Sela
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  Post-ictal psychosis in adolescent Niemann-Pick disease type C.

Authors:  Mark Walterfang; Andrew Kornberg; Sophia Adams; Michael Fietz; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2010-01-13       Impact factor: 4.982

Review 7.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12

8.  Peripheral nerve pathology in Niemann-Pick type C mouse.

Authors:  Y Higashi; S Murayama; P G Pentchev; K Suzuki
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism.

Authors:  Anne Gläser; Franziska Hammerl; Markus H Gräler; Sina M Coldewey; Christin Völkner; Moritz J Frech; Fan Yang; Jiankai Luo; Eric Tönnies; Oliver von Bohlen Und Halbach; Nicola Brandt; Diana Heimes; Anna-Maria Neßlauer; Georg Christoph Korenke; Marta Owczarek-Lipska; John Neidhardt; Arndt Rolfs; Andreas Wree; Martin Witt; Anja Ursula Bräuer
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

10.  Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin.

Authors:  Ting Yu; Andrew P Lieberman
Journal:  PLoS Genet       Date:  2013-04-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.